These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 20136489)

  • 1. Development of a high-throughput UHPLC-MS-based content uniformity method as a tool for assessing dry powder inhalers.
    Medendorp J; Donovan B; Pennington J
    Drug Dev Ind Pharm; 2010 Jul; 36(7):762-72. PubMed ID: 20136489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A uHPLC-MS mathematical modeling approach to dry powder inhaler single agglomerate analysis.
    Pennington J; Lena J; Medendorp J; Ewing G
    Drug Dev Ind Pharm; 2011 Oct; 37(10):1208-16. PubMed ID: 21417607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a directly correlated Raman and uHPLC-MS content uniformity method for dry powder inhalers through statistical design, chemometrics and mathematical modeling.
    Seabrooks L; Canfield N; Pennington J
    Drug Dev Ind Pharm; 2016 Sep; 42(9):1515-23. PubMed ID: 26902663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adhesion forces in interactive mixtures for dry powder inhalers--evaluation of a new measuring method.
    Lohrmann M; Kappl M; Butt HJ; Urbanetz NA; Lippold BC
    Eur J Pharm Biopharm; 2007 Sep; 67(2):579-86. PubMed ID: 17418548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In-vitro characterisation of metered dose inhaler versus dry powder inhaler glucocorticoid products: influence of inspiratory flow rates.
    Feddah MR; Brown KF; Gipps EM; Davies NM
    J Pharm Pharm Sci; 2000; 3(3):318-24. PubMed ID: 11177650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parametric two-tier sequential quality assurance test of delivery dose uniformity of multiple-dose inhaler and dry powder inhaler drug products.
    Tsong Y; Shen M; Lostritto RT; Poochikian GK
    J Biopharm Stat; 2008; 18(5):976-84. PubMed ID: 18781529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Air classifier technology (ACT) in dry powder inhalation Part 4. Performance of air classifier technology in the Novolizer multi-dose dry powder inhaler.
    de Boer AH; Hagedoorn P; Gjaltema D; Goede J; Frijlink HW
    Int J Pharm; 2006 Mar; 310(1-2):81-9. PubMed ID: 16442246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality assurance test of delivered dose uniformity of multiple-dose inhaler and dry powder inhaler drug products.
    Tsong Y; Dong X; Shen M; Lostritto RT
    J Biopharm Stat; 2015; 25(2):328-38. PubMed ID: 25357132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel dry powder inhaler formulation of glucagon with addition of citric acid for enhanced pulmonary delivery.
    Onoue S; Yamamoto K; Kawabata Y; Hirose M; Mizumoto T; Yamada S
    Int J Pharm; 2009 Dec; 382(1-2):144-50. PubMed ID: 19703531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can patients use all dry powder inhalers equally well?
    Gustafsson P; Taylor A; Zanen P; Chrystyn H
    Int J Clin Pract Suppl; 2005 Dec; (149):13-8. PubMed ID: 16279998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Highly reproducible powder aerosolisation for lung delivery using powder-specific electromechanical vibration.
    Crowder TM
    Expert Opin Drug Deliv; 2005 May; 2(3):579-85. PubMed ID: 16296776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LC-MS/TOF and UHPLC-MS/MS study of in vivo fate of rifamycin isonicotinyl hydrazone formed on oral co-administration of rifampicin and isoniazid.
    Prasad B; Singh S
    J Pharm Biomed Anal; 2010 Jul; 52(3):377-83. PubMed ID: 19692195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategy of accelerated method development for high-throughput bioanalytical assays using ultra high-performance liquid chromatography coupled with mass spectrometry.
    Liu G; Snapp HM; Ji QC; Arnold ME
    Anal Chem; 2009 Nov; 81(22):9225-32. PubMed ID: 19856950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of spectrofluorometry for evaluation of dry powder inhalers in vitro.
    Srichana T; Suedee R; Srisudjai P
    Pharmazie; 2003 Feb; 58(2):125-9. PubMed ID: 12641330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adherence logger for a dry powder inhaler: a new device for medical adherence research.
    Bogen D; Apter AJ
    J Allergy Clin Immunol; 2004 Oct; 114(4):863-8. PubMed ID: 15480328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dry powder inhaler formulation.
    Telko MJ; Hickey AJ
    Respir Care; 2005 Sep; 50(9):1209-27. PubMed ID: 16122404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Separation and quantification of two diastereomers of a Drug Candidate in rat plasma by ultra-high pressure liquid chromatography/mass spectrometry.
    Wang H; Edom RW; Kumar S; Vincent S; Shen Z
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jul; 854(1-2):26-34. PubMed ID: 17442640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do all dry powder inhalers show the same pharmaceutical performance?
    Taylor A; Gustafsson P
    Int J Clin Pract Suppl; 2005 Dec; (149):7-12. PubMed ID: 16279997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of a cognitive ergonomics approach to compare usability of a multidose dry powder inhaler and a capsule dry powder inhaler: an open-label, randomized, controlled study.
    Franks M; Briggs P
    Clin Ther; 2004 Nov; 26(11):1791-9. PubMed ID: 15639691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measuring charge and mass distributions in dry powder inhalers using the electrical Next Generation Impactor (eNGI).
    Hoe S; Traini D; Chan HK; Young PM
    Eur J Pharm Sci; 2009 Sep; 38(2):88-94. PubMed ID: 19559086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.